Eye
Preseptal Cellulitis
search
Preseptal Cellulitis
, Periorbital Cellulitis
See Also
Orbital Cellulitis
Red Eye
Erysipelas
Pathophysiology
Preseptal Cellulitis is a
Eyelid
soft tissue infection
Thin fibrous, septal membrane extends from orbital rim to lid margin
Forms a periosteal extension or septum that prevents extension or lid disease to orbit
Preseptal Cellulitis infections form anterior to the fibrous septum
Contrast with
Orbital Cellulitis
which involves the deeper tissues (esp. ethmoid or
Maxillary Sinus
itis)
Epidemiology
Typical onset at age 18 months to 3 years
Causes
Local
Eyelid
disease
Hordeolum
Chalazion
Eyelid
Trauma
(e.g.
Insect Bite
) with secondary infection (e.g.
Impetigo
)
Dental abscess or infection with local spread
Sinusitis
with local extension
Uncommon in Preseptal Cellulitis
Sinusitis
is usually precursor to
Orbital Cellulitis
Organisms
Trauma
Staphylococcus aureus
Group A Streptococcus
Bacteremia (less common with modern
Immunization
s)
Streptococcus Pneumoniae
Haemophilus
Influenza
e
Symptoms
Acute
Swollen Red Eyelid
No fever
No orbital pain or
Extraocular Movement
pain
Contrast with painful
Extraocular Movement
s in
Orbital Cellulitis
Signs
Periorbital rash
Pink, violaceous swelling of lid margins
Multiple features differentiate Periorbital Cellulitis from the worrisome
Orbital Cellulitis
No
Extraocular Movement
pain or weakness (
Ophthalmoplegia
)
No
Proptosis
Normal
Vision
Normal pupil reflexes
No
Conjunctiva
l injection (
Conjunctivitis
)
No cells and flare (
Iritis
)
No limitation or pain on eye movement
No
Chemosis
No retrobulbar globe pressure
No
Papilledema
Differential Diagnosis
See
Eyelid Inflammation
Orbital Cellulitis
Inflames or entraps extraocular
Muscle
s with painful or reduced
Extraocular Movement
May be associated with
Diplopia
and disconjugate gaze
Management
Admit all cases of
Orbital Cellulitis
Typical Preseptal Cellulitis may be treated outpatient with oral
Antibiotic
s and close interval follow-up
Close observation to rule out
Orbital Cellulitis
Hospitalize and treat
Parenteral
ly with broad spectrum
Antibiotic
s if evidence of bacteremia or toxicity
See
Orbital Cellulitis
Lumbar Puncture
if suspect bacteremia source
Antibiotic
Course: 10 days
Two
Antibiotic
regimen is controversial
Sanford recommends starting with two agents, the second agent for added
MRSA
coverage
Uptodate recommends single drug empiric coverage starting without
MRSA
(which they note is uncommon)
Antibiotic
1 (choose one): Primary Preseptal Cellulitis coverage
Amoxicillin
-Clavulanate (
Augmentin
)
Adult Immediate Release: 875 mg orally every 12 hours
Adult Extended Release: 2000 mg orally every 12 hours
Child: 45 mg/kg/day (90 mg/kg if resistance suspected) divided every 12 hours up to adult dosing
Cefpodoxime
(
Vantin
)
Adult (and age >=12 years): 400 mg orally every 12 hours
Child (age <12 years): 10 mg/kg/day divided every 12 hours orally (up to 200 mg/dose)
Cefuroxime
(
Ceftin
)
Adult: 500 mg orally every 12 hours
Child: 20 to 30 mg/kg/day (up to 1000 mg/day) orally divided twice daily
Cefprozil
(
Cefzil
)
Identical dosing to
Cefuroxime
Cefdinir
(
Omnicef
)
Adult: 300 mg orally twice daily
Child: 14 mg/kg/day (up to 600 mg/day) divided every 12 to 24 hours
Levofloxacin
(
Levaquin
)
Adult: 600 mg orally daily
Child: 10 to 20 mg/kg divided once to twice daily orally
Relative contraindication due to risk of
Arthropathy
in juvenile animals
However, human studies have not found signficant
Arthropathy
in children
Antibiotic
2 (choose one):
MRSA
Coverage (per Sanford protocol)
Trimethoprim Sulfamethoxazole
(
Septra
,
Bactrim
)
Doxycycline
Clindamycin
References
(2023) Sanford Guide, accessed 7/1/2023
Gappy and Archer (2024) Preseptal Cellulitis, Uptodate, accessed on IOS, 7/22/2024
Complications
Orbital Cellulitis
(from contigious extension)
Uncommon (<10% of
Orbital Cellulitis
extends from Preseptal Cellulitis)
Most
Orbital Cellulitis
is an extension from ethmoid or
Maxillary Sinus
itis
Intracerebral extension of Preseptal Cellulitis is rare without
Orbital Cellulitis
extension
Protective fibrous layer prevents extension
References
Williams (2017) Crit Dec Emerg Med 31(2): 3-12
Broder (2023) Crit Dec Emerg Med 37(11): 20-2
Givner (2002) Pediatr Infect Dis 21:1157-8 [PubMed]
Type your search phrase here